Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure

By Yebin Jiang, Jenny Zhao, B. Mitlak, O. Wang, H. Genant, E. Eriksen. Journal of Bone and Mineral Research, 2003

605 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Altered endochondral bone development in matrix metalloproteinase 13-deficient mice (2004, methodology): “Three-dimensional trabecular structural parameters were measured directly, as previously described (Jiang et al., 2003).”
Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. (2005, background): “Such improvements in cortical bone architecture with teriparatide treatment are now beginning to be documented in humans using a variety of techniques, including histomorphometry (40, 46), peripheral quantitative computed tomography (QCT) (58–61), radiogrammetry (62), and absorptiometric assessment ”